Actinium Pharmaceuticals, Inc. (AMEX:ATNM) went down by -1.71% from its latest closing price when compared to the 1-year high value of $0.62 and move down -72.22%, while ATNM stocks collected -19.00% of loss with the last five trading sessions. Press Release reported on 06/19/20 that Actinium Pharmaceuticals, Inc. Announces Closing of $25.0 Million Public Offering
Actinium Pharmaceuticals, Inc. (AMEX:ATNM) Worth an Investment?
Actinium Pharmaceuticals, Inc. (AMEX: ATNM) The 36 Months beta value for ATNM stocks is at 1.52, while of the analysts out of 0 who provided ratings for Actinium Pharmaceuticals, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $2.30 which is -$0.36 below current price. ATNM currently has a short float of 0.89% and public float of 299.38M with average trading volume of 13.84M shares.
ATNM Market Performance
ATNM stocks went down by -19.00% for the week, with the monthly jump of 67.56% and a quarterly performance of 77.67%, while its annual performance rate touched 44.88%. The simple moving average for the period of the last 20 days is -2.98% for ATNM stocks with the simple moving average of 49.76% for the last 200 days.
Analysts’ Opinion on Actinium Pharmaceuticals, Inc. (AMEX:ATNM)
Many brokerage firms have already submitted their reports for ATNM stocks, with B. Riley FBR, Inc. repeating the rating for ATNM shares by setting it to “Buy”. The predicted price for ATNM socks in the upcoming period according to B. Riley FBR, Inc. is $2.75 based on the research report published on December 6, 2017.
ROTH Capital, on the other hand, stated in their research note that they expect to see ATNM stock at the price of $6. The rating they have provided for ATNM stocks is “Buy” according to the report published on October 23, 2017.
Maxim Group gave “Buy” rating to ATNM stocks, setting the target price at $3 in the report published on September 14, 2017.
ATNM Stocks 36.19% Far from 50 Day Moving Average
After a stumble in the market that brought ATNM to its low price for the period of the last 52 weeks, Actinium Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -42.52% of loss for the given period.
The stock volatility was left at 16.79%, however, within the period of a single month, the volatility rate increased by 12.40%, while the shares surge at the distance of +71.51% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +65.69% upper at the present time.
In the course of the last 5 trading sessions, ATNM went down by -19.00%, which changed the moving average for the period of 200 days to the total of +54.96% of gains for the stock in comparison to the 20-day moving average settled at $0.3748. In addition, Actinium Pharmaceuticals, Inc. saw 63.71% in overturn over the period of a single year with a tendency to cut further gains.
ATNM Stock Fundamentals
Based on Actinium Pharmaceuticals, Inc. (ATNM), the company’s capital structure generated 25.30 points for debt to equity in total, while total debt to capital is set at the value of 20.19.